CRISPR genome editing clicks for amyloid cardiomyopathy. New @NEJM #AHA24 https://
nejm.org/doi/full/10.10
56/NEJMoa2412309
… A Phase 1 study with marked reduction of serum TTR @dr_m_fontana @ucl

→ View original post on X — @erictopol,